Frank Dekker awarded NWO ENW-M1 grant
Associate professor Frank Dekker was awarded an NWO ENW-M1 grant for a research project on Hypoxia-induced drug activation to enhance ferroptosis as a new treatment strategy for Acute Myeloid Leukaemia.
The current therapy for Acute Myeloid Leukemia (AML) suffers from development of therapy resistance. Cancer cells responsible for development of therapy resistance reside in the bone marrow in a low oxygen environment. A mechanism that enables killing of therapy resistant cancers cells is called ferroptosis. The project aims to enhance the ferroptosis process by development of a novel therapeutic strategy. This strategy involves development of molecules that are activated by low oxygen concentrations and trigger degradation of proteins that suppress ferroptosis and thus enhance this process. Thus, this strategy will enable eradication of cancer cells that are resistant to chemotherapy, which will postpone or abolish relapse into cancer progression.
Last modified: | 22 September 2022 2.35 p.m. |
More news
-
21 May 2024
Results of 2024 University elections
The votes have been counted and the results of the University elections are in!
-
13 May 2024
Trapping molecules
In his laboratory, physicist Steven Hoekstra is building an experimental set-up made of two parts: one that produces barium fluoride molecules, and a second part that traps the molecules and brings them to an almost complete standstill so they can...